Cargando…
Toward the realization of cardiac regenerative medicine using pluripotent stem cells
Heart transplantation (HT) is the only radical treatment available for patients with end-stage heart failure that is refractory to optimal medical treatment and device therapies. However, HT as a therapeutic option is limited by marked donor shortage. To overcome this difficulty, regenerative medici...
Autores principales: | Kishino, Yoshikazu, Fujita, Jun, Tohyama, Shugo, Okada, Marina, Tanosaki, Sho, Someya, Shota, Fukuda, Keiichi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6956487/ https://www.ncbi.nlm.nih.gov/pubmed/31938077 http://dx.doi.org/10.1186/s41232-019-0110-4 |
Ejemplares similares
-
Metabolism of human pluripotent stem cells and differentiated cells for regenerative therapy: a focus on cardiomyocytes
por: Tanosaki, Sho, et al.
Publicado: (2021) -
Manipulation of Pluripotent Stem Cell Metabolism for Clinical Application
por: Tohyama, Shugo, et al.
Publicado: (2017) -
The Present State and Future Perspectives of Cardiac Regenerative Therapy Using Human Pluripotent Stem Cells
por: Soma, Yusuke, et al.
Publicado: (2021) -
Scalable manufacturing of clinical‐grade differentiated cardiomyocytes derived from human‐induced pluripotent stem cells for regenerative therapy
por: Morita, Yuika, et al.
Publicado: (2022) -
Tryptophan Metabolism Regulates Proliferative Capacity of Human Pluripotent Stem Cells
por: Someya, Shota, et al.
Publicado: (2021)